-
1
-
-
27244435229
-
Serum interleukin (IL)-1, IL-2, sIL-2Ra, IL-6 and thrombopoietin levels in patients with chronic myeloproliferative diseases
-
[J]
-
Panteli KE, Hatzimichael EC, Bouranta PK, Katsaraki A, Seferiadis K, Stebbing J, Bourantas KL. Serum interleukin (IL)-1, IL-2, sIL-2Ra, IL-6 and thrombopoietin levels in patients with chronic myeloproliferative diseases [J]. Br J Haematol, 2005, 130 (5): 709-715.
-
(2005)
Br J Haematol
, vol.130
, Issue.5
, pp. 709-715
-
-
Panteli, K.E.1
Hatzimichael, E.C.2
Bouranta, P.K.3
Katsaraki, A.4
Seferiadis, K.5
Stebbing, J.6
Bourantas, K.L.7
-
2
-
-
33845865424
-
-
Chinese source
-
Chinese source. 1998, 168-194.
-
, vol.1998
, pp. 168-194
-
-
-
3
-
-
33845882639
-
-
Chinese source
-
Chinese source. 1986, 9 (4):247-249.
-
(1986)
, vol.9
, Issue.4
, pp. 247-249
-
-
-
5
-
-
0030057331
-
Control of apoptosis in hematopoiesis and leukemia by cytokines, tumor suppressor and oncogenes
-
[J]
-
Lotem J, Sachs L. Control of apoptosis in hematopoiesis and leukemia by cytokines, tumor suppressor and oncogenes [J]. Leukemia, 1996, 10(6): 925-931.
-
(1996)
Leukemia
, vol.10
, Issue.6
, pp. 925-931
-
-
Lotem, J.1
Sachs, L.2
-
6
-
-
0031429943
-
Signaling mechanism through gp130: A model of the cytokine system
-
[J]
-
Hirano T, Nakajima K, Hibi M. Signaling mechanism through gp130: a model of the cytokine system [J]. Cytokine Growth Factor Rev, 1997, 8(4): 241-252.
-
(1997)
Cytokine Growth Factor Rev
, vol.8
, Issue.4
, pp. 241-252
-
-
Hirano, T.1
Nakajima, K.2
Hibi, M.3
-
7
-
-
0036175513
-
Leukemia inhibitory factor enhances bFGF-induced IL-6 synthesis in osteoblasts: Involvement of JAK2/STAT3
-
[J]
-
Kozawa O, Otsuka T, Uematsu T. Leukemia inhibitory factor enhances bFGF-induced IL-6 synthesis in osteoblasts: involvement of JAK2/STAT3 [J]. Cell Signal, 2002, 14(4): 311-315.
-
(2002)
Cell Signal
, vol.14
, Issue.4
, pp. 311-315
-
-
Kozawa, O.1
Otsuka, T.2
Uematsu, T.3
-
8
-
-
32944479992
-
Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells
-
[J]
-
Isomoto H, Kobayashi S, Werneburg NW, Bronk SF, Guicciardi ME, Frank DA, et al. Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells [J]. Hepatology, 2005, 42 (6): 1329-1338.
-
(2005)
Hepatology
, vol.42
, Issue.6
, pp. 1329-1338
-
-
Isomoto, H.1
Kobayashi, S.2
Werneburg, N.W.3
Bronk, S.F.4
Guicciardi, M.E.5
Frank, D.A.6
-
9
-
-
0028832395
-
Serum concentrations of E-selectin, P-selectin, ICAM-1 and interleukin-6 in acute leukemia patients with chemotherapy-induced leukopenia and bacterial infections
-
[J]
-
Bruserud O, Akselen PE, Bergheim J, Nesthus I. Serum concentrations of E-selectin, P-selectin, ICAM-1 and interleukin-6 in acute leukemia patients with chemotherapy-induced leukopenia and bacterial infections [J]. Br J Haematol, 1995, 91 (2) : 394-402.
-
(1995)
Br J Haematol
, vol.91
, Issue.2
, pp. 394-402
-
-
Bruserud, O.1
Akselen, P.E.2
Bergheim, J.3
Nesthus, I.4
-
10
-
-
0034970326
-
Critical contribution of IFN-γ and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of α-galactosylceramide
-
[J]
-
Hayakawa Y, Takeda K, Yagita H, Smyth MJ, Kaer LV. Critical contribution of IFN-γ and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of α-galactosylceramide [J]. Eur J Immunol, 2001, 31 (6): 1720-1727.
-
(2001)
Eur J Immunol
, vol.31
, Issue.6
, pp. 1720-1727
-
-
Hayakawa, Y.1
Takeda, K.2
Yagita, H.3
Smyth, M.J.4
Kaer, L.V.5
-
11
-
-
0035165729
-
Perforin and interferon-γ activities independently control tumor initiation, growth and metastasis
-
[J]
-
Street SEA, Crentney E, Smyth MJ. Perforin and interferon-γ activities independently control tumor initiation, growth and metastasis [J]. Blood, 2001, 97(1): 192-197.
-
(2001)
Blood
, vol.97
, Issue.1
, pp. 192-197
-
-
Street, S.E.A.1
Crentney, E.2
Smyth, M.J.3
-
12
-
-
0036720437
-
IFN-γ-mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, α-galactosylceramide
-
[J]
-
Hayakawa Y, Takeda K, Yagita H, Smyth MJ, Kaer LV, Okumura K, et al. IFN-γ-mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, α-galactosylceramide. [J]. Blood, 2002, 100(5): 1728-1733.
-
(2002)
Blood
, vol.100
, Issue.5
, pp. 1728-1733
-
-
Hayakawa, Y.1
Takeda, K.2
Yagita, H.3
Smyth, M.J.4
Kaer, L.V.5
Okumura, K.6
|